Details for Patent: 10,357,609

Which drugs does patent 10,357,609 protect, and when does it expire?

Patent 10,357,609 protects XYOSTED (AUTOINJECTOR) and is included in one NDA.

This patent has twenty-nine patent family members in ten countries.

Summary for Patent: 10,357,609

Title:	Needle assisted jet injection device having reduced trigger force
Abstract:	An exemplary embodiment of an injector includes a trigger mechanism, an energy source, and a user-operable firing-initiation member. The trigger mechanism can include a floating trigger member having a retaining portion, a ram assembly having a ram configured to pressurize a medicament container for expelling a medicament therefrom, the ram assembly further having a floating trigger engagement member configured to engage the retaining portion of the floating trigger member when the floating trigger member is in a pre-firing condition. The energy source can be associated with the ram for powering the ram to expel the medicament, and the user-operable firing-initiation member can be operable for causing an axial rotation of the floating trigger member from the pre-firing condition to a firing condition in which the floating trigger engagement member is released from the retaining portion to allow the energy source to fire the ram.
Inventor(s):	Kramer; Thomas (Andover, MN), Rust; Matthew H. (Hudson, WI), Goudreau; Paul M. (St. Paul, MN), Hoeft; Peter A. (Seattle, WA), Sund; Julius C. (Plymouth, MN), Sadowski; Peter L. (Woodbury, MN), Travanty; Michael (S. Minneapolis, MN), Madsen; Patrick (Litchfield, MN)
Assignee:	Antares Pharma, Inc. (Ewing, NJ)
Application Number:	15/155,804
Patent Claim Types: see list of patent claims	Dosage form;

Drugs Protected by US Patent 10,357,609

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-001	Sep 28, 2018		RX	Yes	Yes			Y
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-002	Sep 28, 2018		RX	Yes	Yes			Y
Antares Pharma Inc	XYOSTED (AUTOINJECTOR)	testosterone enanthate	SOLUTION;SUBCUTANEOUS	209863-003	Sep 28, 2018		RX	Yes	Yes			Y

International Family Members for US Patent 10,357,609

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013203784
Canada	2868500
Canada	2900672
China	104487114